3Bland KI, Copeland EM, Preface. The breast: comprehensive management of benign and malignant disease [ M ]. 2nd ed. W.B: Saunders Company, 1998:XXI-XXII
4Catherine Goehring, Alfredo Morabia. Epidemiology of benign breast disease with special attention to histologic types [J]. Epidemiol Rev, 1997, 19(2): 310-327.
5Hughes LE, Mansel RE, Webster DJT. Aberrations of normal development and involution (ANDI): a new perspective on pathogenesis and nomenclature of benign breast disorders [J]. Lancet ,1987,2( 11 ):1316-1319.
6Kleer CG, Tseng MD, Gutsch DE, et al. Detection of Epstein-BaiT virus in rapidly growing fibroadenomas of the breast in immunosuppressed hosts [J]. Mod Pathol ,2002,15 (7): 759-764.
7Carter BA, Page DL, Schuyler P ,et al. No elevation in long-term breast carcinoma risk for women with fibroadenomas that contain atypical hyperplasia[J]. Cancer, 2001,92(1):30-36.
8l1-Wakeel H, Umpleby HC. Systematic review of fibroadenoma as a risk factor for breast cancer [J]. Breast, 2003,12 (5): 302-307.
9Agoff SN, Lawton TJ. Papillary lesions of the breast with and withnut atypical ductal hyperplasia: can we accurately predict benign behavior from core needle biopsy? [J ]. Am J Clin Pathol, 2004,122 ( 3 ) :440-443.
10Bazzocchi F, Santini D, Martinelli G, el al. Juvenile papillomatosis (epitheliosis) of the breast: a clinical and pathologic study of 13 cases [ J ]. Am J Clin Pathol,1986,86(6) :745-748.
